Description

For vaccination of healthy horses, 6 months of age or older, as an aid in the prevention of Eastern, Western and Venezuelan Encephalomyelitis and Tetanus, and as an aid in the control of respiratory disease caused by Equine Influenza Virus and Equine Herpesvirus and as an aid in the reduction of Influenza virus shedding. Duration of Immunity (DOI) has been shown to be at least 6 months for Influenza. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow immunization.

A combination of inactivated, purified, concentrated, adjuvanted, tissue culture origin Equine Encephalomyelitis Virus, Eastern, Western, and Venezuelan, Equine Herpesvirus EHV-1 and EHV-4, Equine Influenza Virus subtype A2 including KY 93, KY02, and NM2/93 strains and Tetanus Toxoid. Intervet serological data suggest Influenza cross protection against certain U.S. and European strains, including Kentucky 91, 93, 99, 02, Ohio 03, Newmarket 1/93, Newmarket 2/93, Suffolk 89, and South Africa 03.

Administration and Dosage
For primary immunization, aseptically inject 1 mL intramuscularly and repeat the dose in 3 to 4 weeks. Annual revaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.

Caution
Store at 35° to 45° F (2° to 7° C). Shake well before using. Do not vaccinate within 21 days before slaughter. Local reactions may occur if this product is given subcutaneously. Inject deep into the muscle only. Anaphylactoid reactions may occur.

Top of Page

Reviews